321 related articles for article (PubMed ID: 29080930)
1. Dysfunction of GABAergic neurons in the parafacial zone mediates sleep disturbances in a streptozotocin-induced rat model of sporadic Alzheimer's disease.
Song JZ; Cui SY; Cui XY; Hu X; Ma YN; Ding H; Ye H; Zhang YH
Metab Brain Dis; 2018 Feb; 33(1):127-137. PubMed ID: 29080930
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular streptozotocin-induced Alzheimer's disease-like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex.
Cui SY; Song JZ; Cui XY; Hu X; Ma YN; Shi YT; Luo Y; Ge YR; Ding H; Ye H; Zhang YH
CNS Neurosci Ther; 2018 Dec; 24(12):1241-1252. PubMed ID: 30014576
[TBL] [Abstract][Full Text] [Related]
3. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
4. Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
Thomé GR; Oliveira VA; Chitolina Schetinger MR; Saraiva RA; Souza D; Dorneles Rodrigues OE; Teixeira Rocha JB; Ineu RP; Pereira ME
Chem Biol Interact; 2018 Oct; 294():135-143. PubMed ID: 30120923
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of 5-HT
Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A
J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605
[TBL] [Abstract][Full Text] [Related]
6. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
7. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
Angelova H; Pechlivanova D; Krumova E; Miteva-Staleva J; Kostadinova N; Dzhambazova E; Landzhov B
Amino Acids; 2019 Nov; 51(10-12):1501-1513. PubMed ID: 31520285
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats.
Cevik B; Solmaz V; Yigitturk G; Cavusoğlu T; Peker G; Erbas O
Adv Clin Exp Med; 2017; 26(1):23-29. PubMed ID: 28397428
[TBL] [Abstract][Full Text] [Related]
9. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
Akhtar A; Dhaliwal J; Sah SP
Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
[TBL] [Abstract][Full Text] [Related]
10. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R
Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828
[TBL] [Abstract][Full Text] [Related]
11. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
[TBL] [Abstract][Full Text] [Related]
12. Hypercapnic and Hypoxic Respiratory Response During Wakefulness and Sleep in a Streptozotocin Model of Alzheimer's Disease in Rats.
Vicente MC; Almeida MC; Bícego KC; Carrettiero DC; Gargaglioni LH
J Alzheimers Dis; 2018; 65(4):1159-1174. PubMed ID: 30124447
[TBL] [Abstract][Full Text] [Related]
13. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
14. Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death.
de Oliveira JS; Abdalla FH; Dornelles GL; Adefegha SA; Palma TV; Signor C; da Silva Bernardi J; Baldissarelli J; Lenz LS; Magni LP; Rubin MA; Pillat MM; de Andrade CM
Neurotoxicology; 2016 Dec; 57():241-250. PubMed ID: 27746125
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model.
Elcioğlu HK; Aslan E; Ahmad S; Alan S; Salva E; Elcioglu ÖH; Kabasakal L
Mol Cell Biochem; 2016 Sep; 420(1-2):21-8. PubMed ID: 27443846
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer's pathology.
Kadian M; Saini N; Khera A; Kumar A
Inflammopharmacology; 2024 Apr; 32(2):1545-1573. PubMed ID: 38308793
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type.
Gutierres JM; Carvalho FB; Schetinger MR; Marisco P; Agostinho P; Rodrigues M; Rubin MA; Schmatz R; da Silva CR; de P Cognato G; Farias JG; Signor C; Morsch VM; Mazzanti CM; Bogo M; Bonan CD; Spanevello R
Life Sci; 2014 Feb; 96(1-2):7-17. PubMed ID: 24291256
[TBL] [Abstract][Full Text] [Related]
18. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
[TBL] [Abstract][Full Text] [Related]
19. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
[TBL] [Abstract][Full Text] [Related]
20. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
